Revocation of CTO and Reinstatement to Trade

ZoomMed (TSXV:ZMD) is pleased to announce that the TSX Venture Exchange will be issuing a bulletin to reinstate trading in ZoomMed’s securities for the market opening on February 5, 2018.

As quoted in the press release:

The CTO issued by the Autorité des Marchés Financiers and the Ontario Securities Commission on October 5, 2017, following the inability of ZoomMed to file its annual audited financial statements for the financial year ended on May 31, 2017, has been revoked this day by both the AMF and the OSC following the filling by ZoomMed of all of its continuous disclosure documents provided by the legislation.

Click here to read the full press release.